United States · Industrial & Consumer Products · USD · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average
Amounts in USD; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for KIORA PHARMACEUTICALS INC? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| ROE | -202.11% | - | 108.17% | 49.92% | 33.57% | 25.87% |
|---|---|---|---|---|---|---|
| Sector average | 1.38% | -4.6% | 22.2% | -36.22% | -229.04% | -10.73% |
| ROA | -92.54% | -101.19% | -137.62% | -130.41% | -131.69% | -136.15% |
| Total Assets | $20,130,308.00 | $12,275,618.00 | $12,275,618.00 | $12,275,618.00 | $12,275,618.00 | $12,275,618.00 |
| Net Income | -$16,394,919.00 | -$16,395,369.98 | -$16,893,694.78 | -$16,008,338.86 | -$16,165,581.15 | -$16,713,846.24 |